Why has Cerus's revenue from red blood cell illumination devices dropped by 25% compared to projections for Q3, despite increased marketing efforts?

Introduction

The 25% drop in Cerus's revenue from red blood cell illumination devices in Q3, despite increased marketing efforts, is a critical issue that requires immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal component. Has this drop been observed in previous Q3 periods?

Why it matters: Helps distinguish between cyclical patterns and unique issues. Expected answer: No, this is unprecedented for Q3. Impact on approach: If cyclical, we'd focus on forecasting; if not, we'd investigate recent changes.

• Considering the specificity of the product, I'm curious about the competitive landscape. Have there been any significant market entrants or competitor product launches recently?

Why it matters: External factors could be driving the revenue drop. Expected answer: No major changes in the competitive landscape. Impact on approach: If competition isn't a factor, we'd focus more on internal issues.

• Given the increased marketing efforts, I'm wondering about the conversion rates. Have we seen any changes in the lead-to-sale conversion rates during this period?

Why it matters: Helps isolate whether the issue is with attracting customers or closing sales. Expected answer: Conversion rates have remained stable. Impact on approach: If stable, we'd investigate other parts of the sales funnel.

• Thinking about the product itself, have there been any recent changes to the red blood cell illumination devices or associated services?

Why it matters: Product changes could impact user satisfaction and repurchases. Expected answer: No significant product changes in the last quarter. Impact on approach: If no changes, we'd look at external factors or underlying market shifts.